[PHARMA] QoQ TTM Result on 31-Mar-2002 [#1]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
21-May-2002
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2002
Quarter
31-Mar-2002 [#1]
Profit Trend
QoQ- -3.65%
YoY- 16.78%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
31/12/02 30/09/02 30/06/02 31/03/02 31/12/01 30/09/01 30/06/01 CAGR
Revenue 585,237 594,966 578,889 553,176 543,496 503,335 480,247 14.04%
PBT 61,170 64,797 58,312 52,093 51,604 44,517 41,544 29.33%
Tax -23,829 -26,084 -24,033 -22,413 -20,800 -20,440 -17,894 20.97%
NP 37,341 38,713 34,279 29,680 30,804 24,077 23,650 35.48%
-
NP to SH 37,341 38,713 34,279 29,680 30,804 24,077 23,650 35.48%
-
Tax Rate 38.96% 40.25% 41.21% 43.02% 40.31% 45.92% 43.07% -
Total Cost 547,896 556,253 544,610 523,496 512,692 479,258 456,597 12.88%
-
Net Worth 179,444 172,829 159,457 167,817 160,519 151,781 143,956 15.77%
Dividend
31/12/02 30/09/02 30/06/02 31/03/02 31/12/01 30/09/01 30/06/01 CAGR
Div 3,744 5,002 3,750 3,750 3,750 2,509 2,509 30.48%
Div Payout % 10.03% 12.92% 10.94% 12.64% 12.18% 10.42% 10.61% -
Equity
31/12/02 30/09/02 30/06/02 31/03/02 31/12/01 30/09/01 30/06/01 CAGR
Net Worth 179,444 172,829 159,457 167,817 160,519 151,781 143,956 15.77%
NOSH 99,691 50,095 49,986 49,945 50,006 49,928 49,984 58.24%
Ratio Analysis
31/12/02 30/09/02 30/06/02 31/03/02 31/12/01 30/09/01 30/06/01 CAGR
NP Margin 6.38% 6.51% 5.92% 5.37% 5.67% 4.78% 4.92% -
ROE 20.81% 22.40% 21.50% 17.69% 19.19% 15.86% 16.43% -
Per Share
31/12/02 30/09/02 30/06/02 31/03/02 31/12/01 30/09/01 30/06/01 CAGR
RPS 587.05 1,187.67 1,158.09 1,107.56 1,086.86 1,008.12 960.79 -27.93%
EPS 37.46 77.28 68.58 59.42 61.60 48.22 47.31 -14.37%
DPS 3.76 10.00 7.50 7.50 7.50 5.00 5.00 -17.26%
NAPS 1.80 3.45 3.19 3.36 3.21 3.04 2.88 -26.83%
Adjusted Per Share Value based on latest NOSH - 49,945
31/12/02 30/09/02 30/06/02 31/03/02 31/12/01 30/09/01 30/06/01 CAGR
RPS 40.61 41.28 40.17 38.38 37.71 34.92 33.32 14.05%
EPS 2.59 2.69 2.38 2.06 2.14 1.67 1.64 35.50%
DPS 0.26 0.35 0.26 0.26 0.26 0.17 0.17 32.64%
NAPS 0.1245 0.1199 0.1106 0.1164 0.1114 0.1053 0.0999 15.76%
Price Multiplier on Financial Quarter End Date
31/12/02 30/09/02 30/06/02 31/03/02 31/12/01 30/09/01 30/06/01 CAGR
Date 31/12/02 30/09/02 28/06/02 29/03/02 31/12/01 27/09/01 29/06/01 -
Price 3.80 7.68 7.32 7.32 7.27 5.73 6.36 -
P/RPS 0.65 0.65 0.63 0.66 0.67 0.57 0.66 -1.00%
P/EPS 10.15 9.94 10.67 12.32 11.80 11.88 13.44 -17.02%
EY 9.86 10.06 9.37 8.12 8.47 8.42 7.44 20.59%
DY 0.99 1.30 1.02 1.02 1.03 0.87 0.79 16.18%
P/NAPS 2.11 2.23 2.29 2.18 2.26 1.88 2.21 -3.03%
Price Multiplier on Announcement Date
31/12/02 30/09/02 30/06/02 31/03/02 31/12/01 30/09/01 30/06/01 CAGR
Date 10/04/03 22/11/02 26/08/02 21/05/02 20/02/02 26/11/01 29/08/01 -
Price 3.62 7.36 7.86 7.86 6.77 6.82 6.82 -
P/RPS 0.62 0.62 0.68 0.71 0.62 0.68 0.71 -8.61%
P/EPS 9.66 9.52 11.46 13.23 10.99 14.14 14.41 -23.34%
EY 10.35 10.50 8.72 7.56 9.10 7.07 6.94 30.43%
DY 1.04 1.36 0.95 0.95 1.11 0.73 0.73 26.53%
P/NAPS 2.01 2.13 2.46 2.34 2.11 2.24 2.37 -10.37%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment